cancer treatment

AbbVie Stock Today (ABBV): Near Record Highs on New Cancer Approval, Raised Guidance and Dividend Hike – November 23, 2025

Published: November 23, 2025 – Ticker: NYSE: ABBVThis article is for informational purposes only and is not financial advice. Key takeaways AbbVie stock price today: still near the top of its range U.S. markets are closed today (Sunday), so the

23 November 2025

Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?

Company Overview: Pioneering TIL Therapy in Oncology Iovance Biotherapeutics is focused on developing tumor-infiltrating lymphocyte (TIL) therapies – a novel form of immunotherapy where a patient’s own T cells, harvested from their tumor, are expanded and activated in a lab,

3 November 2025

Biotech · Cancer Research · Immunotherapy · Medical Innovation · NASDAQ:IOVA · Stock Analysis

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Company Overview and Background Acrivon Therapeutics is a Boston-area biotech (NASDAQ: ACRV) founded in 2018, emerging with a mission to revolutionize cancer treatment through precision medicine stockanalysis.com. The company’s name “Acrivon” is derived from “accurate” or “precision,” reflecting its core

3 November 2025

Biotechnology · Cancer Research · Healthcare Innovation · NASDAQ:ACRV · Precision Oncology · Stock Analysis